BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grazioli L, Bondioni MP, Faccioli N, Gambarini S, Tinti R, Schneider G, Kirchin M. Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine. J Gastrointest Cancer 2010;41:221-32. [PMID: 20405242 DOI: 10.1007/s12029-010-9145-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Fergusson J. Investigation and management of hepatic incidentalomas: Liver incidentaloma management. J Gastroenterol Hepatol 2012;27:1772-82. [DOI: 10.1111/j.1440-1746.2012.07236.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Paolantonio P, Laghi A, Vanzulli A, Grazioli L, Morana G, Ragozzino A, Colagrande S. MRI of hepatic epithelioid hemangioendothelioma (HEH). J Magn Reson Imaging. 2014;40:552-558. [PMID: 24677597 DOI: 10.1002/jmri.24391] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
3 Tselikas L, Pigneur F, Roux M, Baranes L, Costentin C, Roche V, Calderaro J, Herin E, Laurent A, Zafrani E. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors. Abdom Radiol (NY). 2017;42:825-832. [PMID: 27704147 DOI: 10.1007/s00261-016-0921-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
4 Cruite I, Santillan C, Mamidipalli A, Shah A, Tang A, Sirlin CB. Liver Imaging Reporting and Data System: Review of Ancillary Imaging Features. Semin Roentgenol 2016;51:301-7. [PMID: 27743566 DOI: 10.1053/j.ro.2016.05.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
5 Kang Y, Lee JM, Kim SH, Han JK, Choi BI. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology. 2012;264:751-760. [PMID: 22798225 DOI: 10.1148/radiol.12112308] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 11.0] [Reference Citation Analysis]
6 Agostini A, Kircher MF, Do RK, Borgheresi A, Monti S, Giovagnoni A, Mannelli L. Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions. Semin Roentgenol 2016;51:317-33. [PMID: 27743568 DOI: 10.1053/j.ro.2016.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
7 Halac U, Dubois J, Mitchell GA. The Liver in Tyrosinemia Type I: Clinical Management and Course in Quebec. Adv Exp Med Biol 2017;959:75-83. [PMID: 28755185 DOI: 10.1007/978-3-319-55780-9_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Zhao X, Huang M, Zhu Q, Wang T, Liu Q. The relationship between liver function and liver parenchymal contrast enhancement on Gd-BOPTA-enhanced MR imaging in the hepatocyte phase. Magnetic Resonance Imaging 2015;33:768-73. [DOI: 10.1016/j.mri.2015.03.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
9 Liu W, Liu X, Peng M, Chen GQ, Liu PH, Cui XW, Jiang F, Dietrich CF. Artificial intelligence for hepatitis evaluation. World J Gastroenterol 2021; 27(34): 5715-5726 [PMID: 34629796 DOI: 10.3748/wjg.v27.i34.5715] [Reference Citation Analysis]
10 Cho ES, Yu JS, Park AY, Woo S, Kim JH, Chung JJ. Feasibility of 5-minute delayed transition phase imaging with 30° flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver, compared with 20-minute delayed hepatocyte phase MRI with standard 10° flip angle. AJR Am J Roentgenol. 2015;204:69-75. [PMID: 25539239 DOI: 10.2214/ajr.13.11903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mamone G, Marrone G, Caruso S, Carollo V, Gentile G, Crino' F, Milazzo M, Luca A. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase. Abdom Imaging 2015;40:2313-22. [PMID: 25962708 DOI: 10.1007/s00261-015-0445-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
12 Haradome H, Grazioli L, Morone M, Gambarini S, Kwee TC, Takahara T, Colagrande S. T2-weighted and diffusion-weighted MRI for discriminating benign from malignant focal liver lesions: diagnostic abilities of single versus combined interpretations. J Magn Reson Imaging 2012;35:1388-96. [PMID: 22246647 DOI: 10.1002/jmri.23573] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
13 van Aalten SM, Witjes CD, de Man RA, Ijzermans JN, Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int. 2012;32:28-37. [PMID: 22098685 DOI: 10.1111/j.1478-3231.2011.02667.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
14 Greiser J, Weigand W, Freesmeyer M. Metal-Based Complexes as Pharmaceuticals for Molecular Imaging of the Liver. Pharmaceuticals (Basel) 2019;12:E137. [PMID: 31527492 DOI: 10.3390/ph12030137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jeon I, Cho ES, Kim JH, Kim DJ, Yu JS, Chung JJ. Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30° Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis. PLoS One 2016;11:e0167701. [PMID: 27936106 DOI: 10.1371/journal.pone.0167701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Haradome H, Grazioli L, Al manea K, Tsunoo M, Motosugi U, Kwee TC, Takaraha T. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging. 2012;35:132-139. [PMID: 21960465 DOI: 10.1002/jmri.22805] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
17 Nie P, Yang G, Guo J, Chen J, Li X, Ji Q, Wu J, Cui J, Xu W. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver. Cancer Imaging. 2020;20:20. [PMID: 32093786 DOI: 10.1186/s40644-020-00297-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
18 Schneider G, Probst T, Kirchin MA, Stroeder J, Fries P, Buecker A. Low-dose gadobenate dimeglumine-enhanced MRI of the kidney for the differential diagnosis of localized renal lesions. Radiol Med 2015;120:1100-11. [PMID: 26088468 DOI: 10.1007/s11547-015-0548-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
19 Kim MJ, Rhee HJ, Jeong HT. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging. AJR Am J Roentgenol. 2012;199:W575-W586. [PMID: 23096201 DOI: 10.2214/ajr.11.8205] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]